✦ LIBER ✦

Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase

✍ Scribed by Harari, D; Tzahar, E; Romano, J; Shelly, M; Pierce, J H; Andrews, G C; Yarden, Y

Book ID: 110062066
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 231 KB
Volume: 18
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1202631

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ZD1839 (Iressa), a novel epidermal growt

ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression

✍ Neil G. Anderson; Tawhid Ahmad; Kai Chan; Richard Dobson; Nigel J. Bundred 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 192 KB 👁 1 views

Overexpression of the growth factor receptors EGFR and erbB2 occurs frequently in several human cancers and is associated with aggressive tumour behaviour and poor patient prognosis. We have investigated the effects of ZD1839 (Iressa), a novel EGFR tyrosine kinase inhibitor, on the growth, in vitro

ChemInform Abstract: Tyrosine Kinase Inh

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 7. 7-Amino-4-(phenylamino)- and 7- Amino-4-((phenylmethyl)amino)pyrido(4,3-d)pyrimidines: A New Class of Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor.

✍ A. M. THOMPSON; A. J. BRIDGES; D. W. FRY; A. J. KRAKER; W. A. DENNY 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB

Absorption of CH330331, a novel 4-anilin

Absorption of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase: comparative studies using in vitro, in situ and in vivo models

✍ Haiyan Sun; Huichang Bi; Min Huang; Dong Liu; Zhenyu Qin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

Tyrosine Kinase Inhibitors. 15. 4-(Pheny

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

✍ Zhou, Hairong; Showalter, H. D. Hollis; Winters, R. Thomas; Smaill, Jeff B.; Pal 📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 253 KB

ChemInform Abstract: Tyrosine Kinase Inh

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 10. Isomeric 4-((3-Bromophenyl)amino) pyrido(d)pyrimidines are Potent ATP Binding Site Inhibitors of the Tyrosine Kinase Function of the Epidermal Growth Factor Receptor (EGFR) .

✍ G. W. REWCASTLE; B. D. PALMER; A. M. THOMPSON; A. J. BRIDGES; D. R. CODY; H. ZHO 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB

ChemInform Abstract: Tyrosine Kinase Inh

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 5. Synthesis and Structure-Activity Relationships for 4-((Phenylmethyl)amino)- and 4-(Phenylamino) quinazolines as Potent Adenosine 5′-Triphosphate Binding Site Inhibitors of the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor.

✍ G. W. REWCASTLE; W. A. DENNY; A. J. BRIDGES; H. ZHOU; D. R. CODY; A. MCMICHAEL; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB